IPSC CENTURY THERAPEUTICS INC Contract Awards 8-K Filing 2024 - Contract Termination Century Therapeutics' collaboration agreement with Bristol-Myers Squibb for developing cancer treatments will end on March 12, 2025, after BMS decided to terminate it without cause.Get access to all SEC 8-K filings of the CENTURY THERAPEUTICS INC